The Clinical Trials section is actively recruiting papers and clinical trials are a priority interest with our Editorial Board. Investigator-initiated, placebo-controlled, double-blind clinical trials are preferred. Open-label studies that are properly controlled will also be considered. The clinical trial must be registered with a recognized clinical trials Web site and the site and registration number should appear on the front page of the paper. Clinical trials that are industry supported must include the statement that all data are made available to the investigators by the sponsor, that the investigators have the right to publish all data, and that the investigators have included a statistical analysis that is independent of any statistical analyses done by the industry sponsor. We encourage submission of clinical trials papers and will have them reviewed in an efficient manner.